Ohcanbohtosat - Nathan Constantine‐Cooke
- Čájehuvvo 1 - 3 / 3
-
1
Real-world effectiveness of upadacitinib in Crohn’s disease: a UK multicentre retrospective cohort study Dahkki Alexander T. Elford, Maria Bishara, Nikolas Plevris, Beatriz Gros, Nathan Constantine‐Cooke, James Goodhand, Nicholas A. Kennedy, Tariq Ahmad, Charlie W. Lees
Almmustuhtton 2024Artigo -
2
Multiple infliximab biosimilar switches appear to be safe and effective in a real‐world inflammatory bowel disease cohort Dahkki Beatriz Gros, Nikolas Plevris, Nathan Constantine‐Cooke, Mathew Lyons, Claire O'Hare, Colin Noble, Ian Arnott, Gareth‐Rhys Jones, Charlie W. Lees, L Derikx
Almmustuhtton 2023Artigo -
3
Real-world Cohort Study on the Effectiveness and Safety of Filgotinib Use in Ulcerative Colitis Dahkki Beatriz Gros, Mairi Goodall, Nikolas Plevris, Nathan Constantine‐Cooke, Alexander T. Elford, Claire O’Hare, Colin Noble, Gareth‐Rhys Jones, Ian Arnott, Charlie W. Lees
Almmustuhtton 2023Artigo
Ohcanreaiddut:
Laktáseaddji fáttát
Calprotectin
Cohort
Disease
Faecal calprotectin
Inflammatory bowel disease
Internal medicine
Medicine
Adverse effect
Gastroenterology
Infliximab
Retrospective cohort study
Ulcerative colitis
Biosimilar
Clinical endpoint
Clinical trial
Cohort study
Colitis
Crohn's disease
Discontinuation
Mercaptopurine
Surgery
Thiopurine methyltransferase